tradmap

NIKI Niki BioSolutions, Inc.

$1.79 -3.24%

Data as of close

Healthcare · Measuring & Controlling Devices, Nec

Niki BioSolutions, Inc. (NIKI) is a healthcare company in the Measuring & Controlling Devices, Nec industry, with a market capitalization of $1 million. Shares last traded at $1.79, 94.9% below their 52-week high. Over the past year the stock is down 89.5%. Net profit margin is -316.0%, below the peer median of -1.6%. Revenue declined 66.7% year over year.

Market Cap
$1M
Shares Out
735,178.4
EPS (TTM)
-$0.19
P/E (TTM)*
—
P/S Ratio
3.05
P/B Ratio
0.06
Dividend / Share
—
Dividend Yield
—
52-Week High
$35.00
52-Week Low
$1.79
Volume (venue)
3
Avg Vol (3m, venue)
2,222.952

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-18.45%
1M
-63.36%
3M
-79.09%
6M
-78.82%
YTD
-83.95%
1Y
-89.47%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. NIKI split history →

Technicals

RSI (14)
19.13
SMA (50)
$5.50
SMA (200)
$8.56
Price vs SMA50
-67.46%
Price vs SMA200
-79.09%
ATR (14)
$0.34

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$431378
Net Income
-$1M
Gross Margin
—
Operating Margin
—
Net Margin
-316.0%
Return on Equity
-5.9%
Return on Assets
-7.3%
Current Ratio
0.78
Debt / Equity
0.01
Revenue Growth (YoY)
-66.7%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2025-12-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Measuring & Controlling Devices, Nec peers

NIKI vs 10 industry peers (Measuring & Controlling Devices, Nec), by market cap. Data as of close

P/S vs peers
3.05 / 4.23 med
-28% discount
Net margin vs peers
-316.0% / -1.6% med
below median
1–10 of 10
TMOThermo Fisher Scientific$258.8B36.595.4614.9%+2.28%
ROKRockwell Automation$49.6B41.295.5313.4%+1.45%
TRMBTrimble Inc.$15.3B—4.04-2.8%-0.39%
ONTOOnto Innovation$9.9B—9.88-0.4%+5.76%
MIRMirion Technologies, Inc.$4.6B157.564.232.7%+2.14%
QSIQuantum-Si Inc$285M—177.29—+4.00%
OWLTOwlet, Inc.$124M—1.08-7.8%-1.74%
GEOSGEOSPACE TECHNOLOGIES CORP$53M—0.58-43.1%-0.49%
BCHTBirchtech Corp.$29M—1.51-15.8%+1.38%
NIKINiki BioSolutions, Inc.$1M———-3.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.